Evidence map›Paper›PMID 36633675›Full record

ArticleEuropean radiology2023

Radiomics-based machine learning models in STEMI: a promising tool for the prediction of major adverse cardiac events.

Emine Sebnem Durmaz, Mert Karabacak, Burak Berksu Ozkara, Osman Aykan Kargın, Utku Raimoglu, Hasan Tokdil, Eser Durmaz, Ibrahim Adaletli

Abstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Emine Sebnem DurmazRadiology Department, Cerrahpasa School of Medicine, Istanbul University - Cerrahpasa, Zip C, Fatih/Istanbul, Turkey. sebnem_memis@hotmail.com.ORCID http://orcid.org/0000-0002-1840-2361
Mert KarabacakCerrahpasa School of Medicine, Istanbul University - Cerrahpasa, Istanbul, Turkey.
Burak Berksu OzkaraCerrahpasa School of Medicine, Istanbul University - Cerrahpasa, Istanbul, Turkey.
Osman Aykan KargınRadiology Department, Cerrahpasa School of Medicine, Istanbul University - Cerrahpasa, Zip C, Fatih/Istanbul, Turkey.
Utku RaimogluCardiology Department, Cerrahpasa School of Medicine, Istanbul University - Cerrahpasa, Istanbul, Turkey.
Hasan TokdilCardiology Department, Cerrahpasa School of Medicine, Istanbul University - Cerrahpasa, Istanbul, Turkey.
Eser DurmazCardiology Department, Cerrahpasa School of Medicine, Istanbul University - Cerrahpasa, Istanbul, Turkey.
Ibrahim AdaletliRadiology Department, Cerrahpasa School of Medicine, Istanbul University - Cerrahpasa, Zip C, Fatih/Istanbul, Turkey.
Istanbul University-Cerrahpaşa · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the potential value of the machine learning (ML) models using radiomic features of late gadolinium enhancement (LGE) and cine images on magnetic resonance imaging (MRI) along with relevant clinical information and conventional MRI parameters for the prediction of major adverse cardiac events (MACE) in ST-segment elevation myocardial infarction (STEMI) patients.

methodsThis retrospective study included 60 patients with the first STEMI. MACE consisted of new-onset congestive heart failure, ventricular arrhythmia, and cardiac death. Radiomic features were extracted from cine and LGE images. Inter-class correlation coefficients (ICCs) were calculated to assess inter-observer reproducibility. LASSO (least absolute shrinkage and selection operator) method was used for radiomic feature selection. Seven separate models using a different combination of the available information were investigated. Classifications with repeat random sampling were done using adaptive boosting, k-nearest neighbor, naive Bayes, neural network, random forest, stochastic gradient descent, and support vector machine algorithms.

resultsOf the 1748 extracted radiomic features, 1393 showed good inter-observer agreement. With LASSO, 25 features were selected. Among the ML algorithms, the neural network showed the highest predictive performance on average (area under the curve (AUC) 0.822 ± 0.181). Of the best-calculated model, the one using clinical parameters, CMRI parameters, and selected radiomic features (model 7), the diagnostic performance was as follows: 0.965 AUC, 0.894 classification accuracy, 0.906 sensitivity, 0.883 specificity, 0.875 positive predictive value (PPV), and 0.912 negative predictive value (NPV).

conclusionThe radiomics-based ML models incorporating clinical and conventional MRI parameters are promising for predicting MACE occurrence in STEMI patients in the follow-up period. KEY POINTS: • Acute coronary occlusion results in variable changes at the cellular level ranging from myocyte swelling to myonecrosis depending on the duration of the ischemia and the metabolic state of the heart, which causes subtle heterogeneous signal changes that are imperceptible to the human eye with cardiac MRI. • Radiomics-based machine learning analysis of cardiac MR images is promising for risk prediction. • Combining MRI-derived parameters and clinical variables increases the accuracy of predictive models.

Indexed as

ST Elevation Myocardial InfarctionBayes TheoremContrast MediaGadoliniumHumansMachine LearningReproducibility of ResultsRetrospective StudiesROC CurveContrast MediaGadoliniumArtificial intelligenceMachine learningMagnetic resonance imagingMyocardial infarction

Identifiers

PMID36633675
OpenAlexW4315703360

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.